SL Science Holding Limite... (SLBT)
NasdaqGM: SLBT
· Echtzeitkurs · USD
2.67
-0.16 (-5.65%)
Zum Schluss: Aug 11, 2026, 3:57 PM
2.77
+3.75%
Vorbörslich: 7:23 AM
SL Science Holding Limited (SLBT) Stock Price, Analysis & Data
-5.65% (1D)
| Geld | 3.16 |
| Marktkapitalisierung | 1.5 Mrd |
| Umsatz (TTM) | 3.27 Mio |
| Nettogewinn (TTM) | -2.37 Mio |
| Beta | n/a |
| EPS (ttm) | -0.01 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 2.07 |
| KUV (TTM) | 457.85 |
| Earnings Date | n/a |
| Brief | 4 |
| Volumen | 45,878 |
| Ø Vol. (20D) | 746,656 |
| Eröffnung | 2.85 |
| Vortagesschluss | 2.83 |
| Tagesspanne | 2.66 - 2.85 |
| 52-Wk Range | 2.54 - 14.50 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über SLBT
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its nam...
Branche Biotechnology
Sektor Healthcare
IPO Datum Feb 5, 2025
Mitarbeiter 14
Börse NasdaqGM
Tickersymbol SLBT
Website https://www.sl-bio.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von SL Science 2.2 Mio, ein Rückgang von -34.68% im Vergleich zum Vorjahr (3.36 Mio). Der Gewinn lag bei -3.82 Mio, ein Anstieg von 220.63 %.
Finanzberichte